Editor-in-Chief honored by world’s largest scientific society

Article

Contemporary OB/GYN Editor-in-Chief Dr Charles Lockwood has been named a Fellow of the American Association for the Advancement of Science (AAAS), one of the most prestigious scientific societies in the world and the largest.

Contemporary OB/GYN Editor-in-Chief Dr Charles Lockwood has been named a Fellow of the American Association for the Advancement of Science (AAAS), one of the most prestigious scienti­fic societies in the world and the largest.                             

Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers, which recognizes individual contributions to innovation, education, and scienti­fic leadership. To be elected requires continuous membership in AAAS for at least 4 years and nomination by the steering group of the Association’s 24 sections, by any 3 Fellows who are current AAAS members, or by the AAAS chief executive officer. The AAAS Council votes on an aggregate list of nominees after each steering group has reviewed nominations for its respective section.

Check out Dr Lockwood's articles

Dr Lockwood is Senior Vice President for University of South Florida Health and Dean of Morsani College of Medicine. He is an internationally recognized healthcare and research leader and recipient of multiple research grants from the National Institutes of Health, the March of Dimes, and other foundations.

Author of 290 peer-reviewed publications and co-editor of 7 major textbooks, he led the research team that discovered fetal ­fibronectin, the ­first biochemical predictor of prematurity.

Related Videos
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit: uvahealth.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.